Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
TEg265sZUqBa38RY